Covered recipient · General Payments record
SAMIR B DESAI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$9,786.84
- Reported across 264 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,675.00 | 1 |
| Food and Beverage | $1,527.75 | 40 |
| Honoraria | $1,200.00 | 1 |
| Education | $108.62 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $1,781.18 | 5 |
| PFIZER INC. | $1,310.95 | 7 |
| Avyxa Pharma, LLC | $423.53 | 1 |
| Pharmacosmos Therapeutics Inc. | $181.08 | 3 |
| US Oncology Corporate, Inc. | $121.77 | 1 |
| Lilly USA, LLC | $108.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $71.15 | 3 |
| Merck Sharp & Dohme Corporation | $63.00 | 3 |
| ABBVIE INC. | $52.35 | 2 |
| E.R. Squibb & Sons, L.L.C. | $45.57 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.35 | 1 |
| Celgene Corporation | $41.84 | 2 |
| JAZZ PHARMACEUTICALS INC. | $39.11 | 1 |
| Incyte Corporation | $27.50 | 1 |
| EMD Serono, Inc. | $26.72 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.75 | 1 |
| Dendreon Pharmaceuticals LLC | $22.43 | 1 |
| GENZYME CORPORATION | $20.95 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.01 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.35 | 1 |
| Genentech USA, Inc. | $18.28 | 1 |
| Apellis Pharmaceuticals, Inc. | $18.14 | 1 |
| ADC Therapeutics America, Inc. | $17.04 | 1 |
| Astellas Pharma US Inc | $15.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.